Westphal Christoph H's Form 4 filing
TScan Therapeutics, Inc. (TCRX) · filed Jul 22, 2021
- Accession no.
- 0000899243-21-029479
- Filed
- Jul 22, 2021
- Trade date
- Jul 20, 2021
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions and 3 derivative transactions. Open-market purchases total $2.00M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Westphal Christoph HCIK 0001291961 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 20, 2021 | Voting Common Stock | CConversionAcquired | +1,145,505 | –F2 | – | 1,145,505 | Indirect | |
| Jul 20, 2021 | Voting Common Stock | PPurchaseAcquired | +133,333 | $15.00 | +$1,999,995 | 1,278,838 | Indirect |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 20, 2021 | Voting Common Stock | CConversionDisposed | −641,848 | –F2 | – | 0 | Indirect | |
| Jul 20, 2021 | Voting Common Stock | CConversionDisposed | −332,594 | –F2 | – | 0 | Indirect | |
| Jul 20, 2021 | Voting Common Stock | CConversionDisposed | −171,063 | –F2 | – | 0 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
Each share of the Issuer's preferred stock automatically converted on a one for one basis into Voting Common Stock immediately prior to the closing of the Issuer's initial public offering, without payment or further consideration. The preferred stock had no expiration date.
Referenced by the price of 1 transaction in Table I and 3 transactions in Table II.